KIDNEY TRANSPLANTATION FROM LIVING DONOR WITH RENAL TUMOR: CLINICAL CASE

2024

Закрытый доступ Метаданные (CSL-JSON)
DOI 10.35805/bsk2024ii003
Достоверность данных 70 средняя
Как считается эта оценка

Складывается из проверяемых признаков самой записи: есть ли у статьи DOI, сколько независимых источников подтвердили её данные, заполнены ли обязательные поля и насколько свежо последнее подтверждение. Снижают оценку расхождения между источниками и отсутствие идентификатора. Значение от 80 означает, что запись опубликована без дополнительной проверки; от 60 до 79 — что она опубликована с пониженной достоверностью и ручная проверка желательна. Запись, выверенную редактором вручную, пересчёт не опускает ниже 90. Это оценка наших данных о статье, а не оценка самой статьи.

Аннотация

Introduction. Renal transplantation is the best treatment option for end-stage renal disease, but organ demand continues to overweight organ supply. The transplantation of kidneys from donors with small renal masses represent a potential avenue to expand the donor pool. We represent the clinical case of kidney transplantation from living related donor with small renal mass and performed literature review of results of these cases. Methods. Саse presentation of kidney transplantation from living related donor with incidental finding of small renal mass. Mass was excised and subsequently kidney was engrafted successfully. Up to date both patients are under follow up during 8 months and any signs of recurrence were seen. Results. Donor kidney was procuredby laparosopic hand-assissted technique. Intraoperatively small renal mass was encountered whereas during preop evaluation renal cyst was diagnosed. Renal mass was excised fully and defect was closed with interruptive suture. Histological evaluation has revealed highly differentiated renal cell carcinoma. Postoperative period was uneventful. Patient was discharged with good graft function. Conclusion. Careful use of kidneys from donors with single renal masses is feasible and safe, with an overall recurrence rate of less than 1.5%. The use of such kidneys could help alleviate the organ shortage crisis.